MedTrace Logo

Dentinal Hypersensitivity Reduction Efficacy Study

NCT06960148 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2026-03-19

No results posted yet for this study

Summary

Assess the clinical efficacy of CSPR Toothpaste containing 8% arginine to provide dentinal hypersensitivity relief

Conditions

  • Sensitivity, Tooth

Interventions

DRUG

CSPR Toothpaste

a commercially available 8% arginine toothpaste

DRUG

Colgate Dental Cream Toothpaste

a commercially available fluoride toothpaste

Sponsors & Collaborators

  • Colgate Palmolive

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-04
Primary Completion
2025-05-13
Completion
2025-05-13

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06960148 on ClinicalTrials.gov